Journal Browser
Volume | Year
Issue
Search
News and Announcements
View All
About the Journal

Shortcuts

1. Aims and Scope

2. Publishing Model

3. Copyright and License to Publish

4. Editorial Board

5. Editorial Policies

6. Peer Review

7. Publication Ethics Statement

8. Journal Information and Statistics

9. Indexing & Archiving

10. Contact

 

1. Aims and Scope

INNOSC Theranostics and Pharmacological Sciences (ITPS) is a peer-reviewed and open-access journal, covering research across disciplines in all aspects of basic, experimental and clinical theranostics (therapeutic and diagnosis) and pharmacological sciences. This multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful research discoveries to researchers, academicians, clinicians, and the public worldwide.

The impact of theragnostics has displayed a great advancement to be utilized efficiently in the fields of therapeutics, medical diagnosis and the associated aspects. Achievement with theranostics has been driven by different approaches in inter- and multi-disciplinary sciences. These approaches are highly motivated in the creation of novel researches, attested by a complete platform for the medicine and diagnosis forms a path from the laboratory to clinics. As a consequence, the focuses on clinical biomarkers, imaging, drug and gene delivery, and a direction towards a personalized medicine became popularized. The major outcome of this journal is to be suitable for all levels of stakeholders and the eventual motto is bridging all disciplines and expanding knowledge sharing.

Pharmacology is a branch of medicine concerned with the uses, effects and modes of action of drugs. This medical science with the impact of understanding the biochemical and therapeutic process gives us the handle to solve the crucial illness or chronic condition in life. It is likewise the science considering the connections amongst chemicals and organisms coordinated to avert, enhance or cure the harmful outcomes of their infections, along these lines it gives prescription weapons against illnesses. The journal aims to publish and promote articles in the advances of pharmacological sciences through the evaluation by top scholars and encourage the translation of preclinical research to the clinical stage.

The journal publishes rigorously the peer-reviewed high-quality original research articles, reviews or mini-reviews, case reports, rapid communications, letters to the editor, preliminary data on innovative research and editorials in all aspects from the basic experiments to clinical phase trials on human diseases, ranging from molecular to higher animals. Furthermore, findings from theories to current cutting-edge technologies are welcomed. Appreciate the submissions of the following appropriate research topics but not limited to

Therapeutics

Medical Diagnosis

In Vivoimaging

In Vitrodiagnosis

Medicinal Chemistry

Cancer Molecular Targets and Therapeutics

Drug Metabolism and Transport

Drug and Gene Delivery

Drug Discovery

Biomarker Discovery

Nanomedicine

Translational Medicine

Personalized Medicine

Clinical Immunology

Biomedical Research

Pharmacological Sciences

 

2. Publishing Model

Gold open access. All articles published by ITPS are made freely and permanently accessible online immediately from the date of publication. For further information, please refer to Open Access.

 

3. Copyright and License to Publish

Articles in ITPS are published under a Creative Commons Attribution 4.0 International (CC BY 4.0). The CC BY 4.0 allows for maximum dissemination and re-use of open access materials and is preferred by many research funding bodies. Under this license users are free to share (copy, distribute and transmit) and remix (adapt) the contribution for any purposes, even commercially, provided that the users appropriately acknowledge the original authors and the source.

Copyright is retained by authors. Authors are required to sign a License to Publish (which can be downloaded from the journal's Author Instructions), granting ITPS, which identifies itself as the original publisher, exclusive rights to publish their articles, and granting any third party the right to use the articles freely as long as the integrity is maintained and the original authors, citation details and publisher are identified.

 

4. Editorial Board

For more information about the editorial team, please refer to Editorial Board.

 

5. Editorial Policies

All manuscripts submitted to ITPS should adhere to AccScience Publishing's Editorial Policies.

 

6. Peer Review

The journal adheres to rigorous peer review and undergoes double-blind peer review. For more details, please refer to Editorial Process.

 

7. Publication Ethics Statement

ITPS fully adheres to the Code of Conduct and the Best Practice Guidelines of Committee on Publication Ethics (COPE).

The Editors of this journal enforce a rigorous peer-review process together with strict ethical policies and standards to guarantee to add high quality scientific works to the field of scholarly publication. Unfortunately, cases of plagiarism, data falsification, image manipulation, inappropriate authorship credit, and the like, do arise. The Editors of ITPS take such publishing ethics issues very seriously and are trained to proceed in such cases with a zero tolerance policy. To verify the originality of content submitted to our journals, we use CrossCheck (powered by iThenticate) to check submissions against previous publications.

 

8. Journal Information and Statistics

ISSN 2705-0823 (Online)

Digital archive: Portico

Frequency: Quarterly

DOI: 10.36922/itps

 

9. Indexing & Archiving

All articles published in ITPS are included in:

CAS

Google Scholar

J-Gate

Crossref

Scilit

CNKI

Singapore Book Publishers Association

 

10. Contact

Please visit the page of Editorial Office for details about different queries.

 

 

Back to top
INNOSC Theranostics and Pharmacological Sciences, Electronic ISSN: 2705-0823 Print ISSN: 2705-0734, Published by AccScience Publishing